AUA 2010 Meeting Coverage
Most men who undergo radiation therapy (RT) for prostate cancer will develop anejaculation, a new study shows.
SAN FRANCISCO—New research implicates erectile dysfunction (ED) as an independent risk factor for high-risk coronary artery calcification.
SAN FRANCISCO—Researchers have identified medical conditions that are independently associated with moderate to severe urinary incontinence (UI) in men. These include major depression, hypertension, and prostatic enlargement.
SAN FRANCISCO—Nocturia, defined as two or more urinations per night, is associated with an increased risk of death, even after adjusting for comorbidities known to increase mortality, according to two new studies presented at the American Urological Association annual meeting.
SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.
SAN FRANCISCO—Urine levels of prostate cancer gene 3 (PCA3) can more specifically predict the presence of prostate cancer than PSA levels, according to new findings.
SAN FRANCISCO—Among obese white men, those with diabetes mellitus (DM) are more likely than non-diabetics to have high-grade prostate cancer discovered on prostate biopsy, according to researchers.
SAN FRANCISCO—Prostate biopsies performed after treatment with 5-alpha reductase inhibitors increase the rate of prostate cancer detection, researchers reported at the American Urological Association annual meeting.
SAN FRANCISCO—Dogs can be trained to detect prostate cancer by smelling urine samples and signaling the presence of certain volatile organic compounds (VOCs) produced by cancer cells, according to French researchers.
SAN FRANCISCO—Finasteride and dutasteride are similarly effective for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia in properly selected patients, but dutasteride is associated with significantly greater sexual side effects and breast complications, researchers reported.
SAN FRANCISCO—Pivotal clinical trials of a novel treatment for premature ejaculation (PE) have yielded promising results, a researcher announced here at a press conference during the American Urological Association annual meeting.
SAN FRANCISCO—Nearly one in five men who undergo radical prostatectomy (RP) for high-risk prostate cancer experience biochemical recurrence (BCR) within two years of surgery, according to the findings of a European study.
SAN FRANCISCO—Prostate cancer patients who have undetectable PSA levels 10 years after undergoing a radical prostatectomy (RP) have a low likelihood of experiencing biochemical recurrence (BCR) of their cancer or of dying from the malignancy, according to researchers.
SAN FRANCISCO—Major depression, hypertension, and prostatic enlargement are independently associated with moderate to severe urinary incontinence (UI) in men aged 40 years and older, according to researchers.
SAN FRANCISCO—Dutasteride treatment may decrease prostatitis-related symptoms, data suggest.
Renal and Urology News Articles
- Tamsulosin Improves Clearance of Large Distal Ureteral Stones
- Calciphylaxis in CKD Patients Linked to Hypercoagulable Conditions
- Ceruloplasmin a Possible Marker of CKD in Sickle Cell Anemia
- Shift in HIV-Associated Kidney Disease Characterized
- Post-Parathyroidectomy Calcium Requirement Linked to Preop ALP
- Cytoreductive Nephrectomy Benefits for Metastatic RCC Demonstrated
- Phosphorus Content Higher in Packaged Meats Listing Phosphate Additives
- High Intakes of Teas, Peas, Soybeans May Increase Prostate Cancer Risk
- More Intense Treatment, Worse Quality of Life in Diabetes
- Hemodialysis CRBSI Outcomes Unaffected by Distance to Nephrologists
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)